Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement

BACKGROUND: As novel systemic therapeutics for patients with atopic dermatitis (AD) are developed, ethical and methodological concerns regarding placebo‐controlled‐trials (PCT) have surfaced. OBJECTIVE: To guide the design and implementation of PCT in AD, focusing on trials with systemic medications...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Eur Acad Dermatol Venereol
Hoofdauteurs: Leshem, Y.A., Bissonnette, R., Paul, C., Silverberg, J.I., Irvine, A.D., Paller, A.S., Cork, M.J., Guttman‐Yassky, E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2019
Onderwerpen:
Guidelines and Position Statements
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594032/
https://ncbi.nlm.nih.gov/pubmed/30859656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.15480
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items